Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
AstraZeneca
Queensland Health
Farmers Insurance
Merck
Chubb
Fish and Richardson
McKesson

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020529

« Back to Dashboard

NDA 020529 describes CONDYLOX, which is a drug marketed by Allergan Sales Llc and is included in two NDAs. It is available from two suppliers. Additional details are available on the CONDYLOX profile page.

The generic ingredient in CONDYLOX is podofilox. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the podofilox profile page.
Summary for 020529
Tradename:CONDYLOX
Applicant:Allergan Sales Llc
Ingredient:podofilox
Patents:0
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020529
Physiological EffectDecreased Mitosis
Suppliers and Packaging for NDA: 020529
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CONDYLOX podofilox GEL;TOPICAL 020529 NDA Allergan, Inc. 0023-6118 N 0023-6118-03
CONDYLOX podofilox GEL;TOPICAL 020529 NDA Actavis Pharma, Inc. 52544-045 N 52544-045-13

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.5%
Approval Date:Mar 13, 1997TE:RLD:Yes

Expired US Patents for NDA 020529

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc CONDYLOX podofilox GEL;TOPICAL 020529-001 Mar 13, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc CONDYLOX podofilox GEL;TOPICAL 020529-001 Mar 13, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Fish and Richardson
Merck
Queensland Health
Accenture
Chubb
US Army
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.